Belite Bio Announces UKs Medicines and Healthcare Products Regulatory Agency Agrees to Conditional Marketing Authorization Application Based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant
November 02, 2025 09:00 ET | Source: Belite Bio, Inc MHRA response…
Cellectis to Report Third Quarter Financial Results on November 7, 2025
NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext…
Lucas GC Limited Announces 1H 2025 Financial Results: Revenue at US$54.01 million with Increases in Gross Margin
October 31, 2025 17:00 ET | Source: Lucas GC Limited NEW YORK,…
AMSC to Report Second Quarter Fiscal Year 2025 Financial Results on November 5, 2025
October 31, 2025 16:33 ET | Source: AMSC AYER, Mass., Oct. 31,…
MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in Peer-Reviewed Publication
Study published in the Journal of Atherosclerosis and Thrombosis demonstrates tipelukast (MN-001…
Bright Minds Biosciences toPresent at Upcoming Conferences
October 30, 2025 18:30 ET | Source: Bright Minds Biosciences NEW YORK,…
CORRECTION Micron Announces Participation in Investor Event
BOISE, Idaho, Oct. 30, 2025 (GLOBE NEWSWIRE) -- In a release issued…
Innovation in the Spotlight: Microvast at All-Energy Australia 2025
MELBOURNE, Australia, Oct. 30, 2025 /PRNewswire/ -- Microvast Holdings, Inc. (NASDAQ: MVST)…
Ascentage Pharma to Participate in Two Upcoming Investor Conferences in November 2025
October 29, 2025 20:00 ET | Source: ASCENTAGE PHARMA GROUP INTERNATIONAL ROCKVILLE,…
authID to Report Third Quarter 2025 Financial Results on November 12, 2025
DENVER, Oct. 29, 2025 (GLOBE NEWSWIRE) -- authID® (Nasdaq: AUID) (“authID” or…